Obesity Medicine

Latest News

BF% outperforms BMI in Predicting Morality risk in young adults: New Findings / image courtesy of University of Florida
Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

July 8th 2025

Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.

Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial
Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial

July 7th 2025

Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial
Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial

June 26th 2025

Viking Advances GLP-1/GIP Agonist VK2735 into Late Stage Clinical Program for Obesity   / image credit ©Viking Therapeutics
Viking Advances GLP-1/GIP Agonist VK2735 into Late Stage Clinical Program for Obesity

June 26th 2025

Mifepristone Reduced HbA1c, Body Weight in Adults with Hypercortisolism and Inadequately Controlled T2D: CATALYST Trial Treatment Phase
Mifepristone Reduced HbA1c, Body Weight in Adults with Hypercortisolism and Inadequately Controlled T2D: CATALYST Trial Treatment Phase

June 24th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.